Filing Details
- Accession Number:
- 0001127602-11-007637
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-25 14:26:50
- Reporting Period:
- 2011-02-23
- Filing Date:
- 2011-02-25
- Accepted Time:
- 2011-02-25 14:26:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1238337 | A Luke Pomilio | C/O Conmed Corp 525 French Road Utica NY 13502-5994 | Vice President & Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-02-23 | 2,000 | $26.38 | 10,632 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-02-23 | 1,521 | $26.38 | 9,111 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2011-02-24 | 15,000 | $26.01 | 24,111 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-02-24 | 15,000 | $26.01 | 9,111 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2011-02-23 | 2,000 | $0.00 | 2,000 | $16.46 |
Common Stock | Options To Purchase Common Stock | Disposition | 2011-02-24 | 15,000 | $0.00 | 15,000 | $17.74 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
8,000 | 2019-06-01 | No | 4 | M | Direct | |
0 | 2013-05-20 | No | 4 | M | Direct |
Footnotes
- The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
- 5 year vesting schedule, 20% vest each year starting 5/20/2004.